Providence Autologous Stem Cell Transplant Program for Clinicians

Providence Autologous Stem Cell Transplant Program offers treatment for a range of diseases, including:
  • Hodgkin’s lymphoma
  • Non-Hodgkin’s lymphoma
  • Multiple myeloma
  • Testicular cancer
  • Other solid tumors
  • Acute leukemia
The program has been accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) since 2000. This accreditation gives our program the ability to perform transplant protocols through the Bone Marrow Transplant Clinical Trials Network (BMT CTN) and the Southwest Oncology Group (SWOG).